Pfizer Inc
PFE· NYSE
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2014 | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|---|
| Revenue | $12.77B | $12.97B | $13.97B | $16.49B |
| Net Income | $2.91B | $14.10B | $3.25B | $2.61B |
| EPS Diluted | $0.45 |
Pfizer Inc · CIK 78003 · Engraved from SEC EDGAR
| $1.98 |
| $0.43 |
| $0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.